The company mission is to develop novel targeted therapeutics for the treatment of unmet or unsatisfied medical conditions including scarring and other fibrotic disorders.
Excaliard has licensed a patented, clinically proven technology with multiple therapeutic opportunities in fibrosis. On the basis of extensive pre-clinical data with this technology, Excaliard anticipates early proof of concept in man.